ALLISON RODRIGUEZ: Open Payments
NPI 1477312759 · DOUGLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 26 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,095 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $190 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| Corcept Therapeutics | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Amgen Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: VRAYLAR, BREZTRI, TRELEGY ELLIPTA, Korlym, CAPLYTA, OTEZLA, REXULTI, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
